标题
AXL as a Target in Breast Cancer Therapy
作者
关键词
-
出版物
Journal of Oncology
Volume 2020, Issue -, Pages 1-15
出版商
Hindawi Limited
发表日期
2020-02-15
DOI
10.1155/2020/5291952
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- AXL confers intrinsic resistance to osimertinib and advances the emergence of tolerant cells
- (2019) Hirokazu Taniguchi et al. Nature Communications
- Axl kinase drives immune checkpoint and chemokine signalling pathways in lung adenocarcinomas
- (2019) Yoko Tsukita et al. Molecular Cancer
- Ampelopsins A and C Induce Apoptosis and Metastasis through Downregulating AxL, TYRO3, and FYN Expressions in MDA-MB-231 Breast Cancer Cells
- (2019) Cheng Huang et al. JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
- Quinolone antibiotic derivatives as new selective Axl kinase inhibitors
- (2019) Li Tan et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Pan-TAM tyrosine kinase inhibitor BMS-777607 enhances anti-PD-1 mAb efficacy in a murine model of triple-negative breast cancer
- (2019) Canan Kasikara et al. CANCER RESEARCH
- Effect of therapeutic GAS6/AXL inhibition of tumor and stromal cells on DNA damage and response to chemotherapy in ovarian cancer.
- (2019) Mary M Mullen et al. JOURNAL OF CLINICAL ONCOLOGY
- A novel human anti‐ AXL monoclonal antibody attenuates tumor cell migration
- (2019) Duan Yanting et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- AXL degradation in combination with EGFR-TKI can delay and overcome acquired resistance in human non-small cell lung cancer cells
- (2019) Donghwa Kim et al. Cell Death & Disease
- Acquired resistance mechanisms to afatinib in HER 2 ‐amplified gastric cancer cells
- (2019) Takahiro Yoshioka et al. CANCER SCIENCE
- Targeting of the AXL receptor tyrosine kinase by small molecule inhibitor leads to AXL cell surface accumulation by impairing the ubiquitin-dependent receptor degradation
- (2019) Markus Lauter et al. Cell Communication and Signaling
- Therapeutic AXL inhibition of tumor and tumor microenvironment stromal cells improves response to chemotherapy in ovarian cancer
- (2019) M.M. Mullen et al. GYNECOLOGIC ONCOLOGY
- MicroRNA‐139 is a predictor of prostate cancer recurrence and inhibits growth and migration of prostate cancer cells through cell cycle arrest and targeting IGF1R and AXL
- (2019) Robert K. Nam et al. PROSTATE
- Axl signaling is an important mediator of tumor angiogenesis
- (2019) Mai Tanaka et al. Oncotarget
- Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
- (2018) Hirokazu Sadahiro et al. CANCER RESEARCH
- A novel AXL chimeric antigen receptor endows T cells with anti-tumor effects against triple negative breast cancers
- (2018) Jing Wei et al. CELLULAR IMMUNOLOGY
- TP-0903 inhibits neuroblastoma cell growth and enhances the sensitivity to conventional chemotherapy
- (2018) Sanja Aveic et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Combination of bemcentinib (BGB324): A first-in-class selective oral AXL inhibitor, with pembrolizumab in patients with triple negative breast cancer and adenocarcinoma of the lung.
- (2018) Murray Yule et al. JOURNAL OF CLINICAL ONCOLOGY
- The Receptor Tyrosine Kinase AXL Is Required at Multiple Steps of the Metastatic Cascade during HER2-Positive Breast Cancer Progression
- (2018) Marie-Anne Goyette et al. Cell Reports
- Abstract 827: Anti-tumor efficacy of BA3011, a novel Conditionally Active Biologic (CAB) anti-AXL-ADC
- (2018) Leslie L. Sharp et al. CANCER RESEARCH
- Abstract 3759: Characterization of INCB081776, a potent and selective dual AXL/MER kinase inhibitor
- (2018) Margaret Favata et al. CANCER RESEARCH
- Abstract 832: An AXL-specific antibody-drug conjugate shows preclinical anti-tumor activity in non-small cell lung cancer, including EGFR-inhibitor resistant NSCLC
- (2018) Louise A. Koopman et al. CANCER RESEARCH
- Comprehensive Characterization of Cancer Driver Genes and Mutations
- (2018) Matthew H. Bailey et al. CELL
- Systems Modeling Identifies Divergent Receptor Tyrosine Kinase Reprogramming to MAPK Pathway Inhibition
- (2018) Allison M. Claas et al. Cellular and Molecular Bioengineering
- A phase 1/2 dose-escalation and expansion study of a conditionally active anti-AXL humanized monoclonal antibody (BA3011) in patients with advanced solid tumors.
- (2018) Jordi Rodon Ahnert et al. JOURNAL OF CLINICAL ONCOLOGY
- MERTK mediates intrinsic and adaptive resistance to AXL-targeting agents
- (2018) Nellie K McDaniel et al. MOLECULAR CANCER THERAPEUTICS
- An integrated approach of bioinformatic prediction and in vitro analysis identified that miR-34a targets MET and AXL in triple-negative breast cancer
- (2018) Shadan Hajalirezay Yazdi et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Soluble AXL is ubiquitously present in malignant serous effusions
- (2018) Karine Flem Karlsen et al. GYNECOLOGIC ONCOLOGY
- Therapeutic activity of DCC‐2036, a novel tyrosine kinase inhibitor, against triple‐negative breast cancer patient‐derived xenografts by targeting AXL/MET
- (2018) Yingying Shen et al. INTERNATIONAL JOURNAL OF CANCER
- Dynamics of Axl Receptor Shedding in Hepatocellular Carcinoma and Its Implication for Theranostics
- (2018) Elisa Holstein et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR-Mutant Non–Small Cell Lung Cancer Cells
- (2018) Kei Namba et al. MOLECULAR CANCER RESEARCH
- Stromal Gas6 promotes the progression of premalignant mammary cells
- (2018) Angelica M. Gomes et al. ONCOGENE
- Chronic lymphocytic leukemia cells from ibrutinib treated patients are sensitive to Axl receptor tyrosine kinase inhibitor therapy
- (2018) Sutapa Sinha et al. Oncotarget
- Anexelekto/MER tyrosine kinase inhibitor ONO-7475 arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse mechanisms
- (2017) Peter P. Ruvolo et al. HAEMATOLOGICA
- Association between AXL, Hippo Transducers, and Survival Outcomes in Male Breast Cancer
- (2017) Anna Di Benedetto et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor
- (2017) Toni M. Brand et al. Science Signaling
- Soluble Axl is an accurate biomarker of cirrhosis and hepatocellular carcinoma development: results from a large scale multicenter analysis
- (2017) Mirko Dengler et al. Oncotarget
- Phospho-AXL is widely expressed in glioblastoma and associated with significant shorter overall survival
- (2017) Julia Onken et al. Oncotarget
- Small molecule inhibitors block Gas6-inducible TAM activation and tumorigenicity
- (2017) Stanley G. Kimani et al. Scientific Reports
- Anexelekto/MER tyrosine kinase inhibitor ONO-7475 arrests growth and kills FMS-like tyrosine kinase 3-internal tandem duplication mutant acute myeloid leukemia cells by diverse mechanisms
- (2017) Peter P. Ruvolo et al. HAEMATOLOGICA
- The receptor tyrosine kinase AXL mediates nuclear translocation of the epidermal growth factor receptor
- (2017) Toni M. Brand et al. Science Signaling
- Requirement of Gamma-Carboxyglutamic Acid Modification and Phosphatidylserine Binding for the Activation of Tyro3, Axl, and Mertk Receptors by Growth Arrest-Specific 6
- (2017) Ke Geng et al. Frontiers in Immunology
- Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease and cancer
- (2016) R B Birge et al. CELL DEATH AND DIFFERENTIATION
- Therapeutic Activity of Anti-AXL Antibody against Triple-Negative Breast Cancer Patient-Derived Xenografts and Metastasis
- (2016) Wilhem Leconet et al. CLINICAL CANCER RESEARCH
- Inhibition of the GAS6/AXL pathway augments the efficacy of chemotherapies
- (2016) Mihalis S. Kariolis et al. JOURNAL OF CLINICAL INVESTIGATION
- Expression of Axl and its prognostic significance in human breast cancer
- (2016) Gaoyuan Jin et al. Oncology Letters
- Reprogramming the immunological microenvironment through radiation and targeting Axl
- (2016) Todd A. Aguilera et al. Nature Communications
- Reduced Proteolytic Shedding of Receptor Tyrosine Kinases Is a Post-Translational Mechanism of Kinase Inhibitor Resistance
- (2016) M. A. Miller et al. Cancer Discovery
- A window of opportunity study of potential tumor and soluble biomarkers of response to preoperative erlotinib in early stage non-small cell lung cancer
- (2016) Adrian G. Sacher et al. Oncotarget
- Axl-EGFR receptor tyrosine kinase hetero-interaction provides EGFR with access to pro-invasive signalling in cancer cells
- (2016) M Vouri et al. Oncogenesis
- Epithelial-Mesenchymal Transition and Breast Cancer
- (2016) Yanyuan Wu et al. Journal of Clinical Medicine
- AXL Mediates Resistance to PI3Kα Inhibition by Activating the EGFR/PKC/mTOR Axis in Head and Neck and Esophageal Squamous Cell Carcinomas
- (2015) Moshe Elkabets et al. CANCER CELL
- A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition
- (2015) M. P. Mak et al. CLINICAL CANCER RESEARCH
- Receptor tyrosine kinase Axl is required for resistance of leukemic cells to FLT3-targeted therapy in acute myeloid leukemia
- (2015) I-K Park et al. LEUKEMIA
- Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth
- (2015) Francesca Zanconato et al. NATURE CELL BIOLOGY
- Targeting MET and AXL overcomes resistance to sunitinib therapy in renal cell carcinoma
- (2015) L Zhou et al. ONCOGENE
- A melanoma subtype with intrinsic resistance to BRAF inhibition identified by receptor tyrosine kinases gene-driven classification
- (2015) Matteo Dugo et al. Oncotarget
- Mesenchymal Cancer Cell-Stroma Crosstalk Promotes Niche Activation, Epithelial Reversion, and Metastatic Colonization
- (2015) Yaiza del Pozo Martin et al. Cell Reports
- Soluble AXL: A Possible Circulating Biomarker for Neurofibromatosis Type 1 Related Tumor Burden
- (2015) Gunnar Johansson et al. PLoS One
- Mechanisms of AXL overexpression and function in Imatinib-resistant chronic myeloid leukemia cells
- (2015) Maeva Dufies et al. Oncotarget
- Axl as a mediator of cellular growth and survival
- (2015) Haley Axelrod et al. Oncotarget
- Inhibition of Axl improves the targeted therapy against ALK-mutated neuroblastoma
- (2014) Fei Xu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Yes-associated protein 1 (YAP1) promotes human gallbladder tumor growth via activation of the AXL/MAPK pathway
- (2014) Maolan Li et al. CANCER LETTERS
- AXL Inhibition Sensitizes Mesenchymal Cancer Cells to Antimitotic Drugs
- (2014) C. Wilson et al. CANCER RESEARCH
- AXL Mediates Resistance to Cetuximab Therapy
- (2014) T. M. Brand et al. CANCER RESEARCH
- Axl receptor tyrosine kinase expression in breast cancer
- (2014) Timothy M D'Alfonso et al. JOURNAL OF CLINICAL PATHOLOGY
- Axl Phosphorylates Elmo Scaffold Proteins To Promote Rac Activation and Cell Invasion
- (2014) Afnan Abu-Thuraia et al. MOLECULAR AND CELLULAR BIOLOGY
- PhosphoSitePlus, 2014: mutations, PTMs and recalibrations
- (2014) Peter V. Hornbeck et al. NUCLEIC ACIDS RESEARCH
- Direct regulation of GAS6/AXL signaling by HIF promotes renal metastasis through SRC and MET
- (2014) Erinn B. Rankin et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Phyllodes tumor of the breast: role of Axl and ST6GalNAcII in the development of mammary phyllodes tumors
- (2014) Dongliang Ren et al. TUMOR BIOLOGY
- Activation of HER3 Interferes with Antitumor Effects of Axl Receptor Tyrosine Kinase Inhibitors: Suggestion of Combination Therapy
- (2014) Robert Torka et al. NEOPLASIA
- TIG1 Promotes the Development and Progression of Inflammatory Breast Cancer through Activation of Axl Kinase
- (2013) X. Wang et al. CANCER RESEARCH
- AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer
- (2013) P. D. Dunne et al. CLINICAL CANCER RESEARCH
- AXL and MET crosstalk to promote gonadotropin releasing hormone (GnRH) neuronal cell migration and survival
- (2013) Smita Salian-Mehta et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- AXL induces epithelial-to-mesenchymal transition and regulates the function of breast cancer stem cells
- (2013) M K Asiedu et al. ONCOGENE
- Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy
- (2013) W Leconet et al. ONCOGENE
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- The Receptor AXL Diversifies EGFR Signaling and Limits the Response to EGFR-Targeted Inhibitors in Triple-Negative Breast Cancer Cells
- (2013) A. S. Meyer et al. Science Signaling
- Differential Expression of Axl and Correlation with Invasion and Multidrug Resistance in Cancer Cells
- (2012) Yongfu Zhao et al. CANCER INVESTIGATION
- ABL Regulation by AXL Promotes Cisplatin Resistance in Esophageal Cancer
- (2012) J. Hong et al. CANCER RESEARCH
- Phosphoproteomics Identifies Driver Tyrosine Kinases in Sarcoma Cell Lines and Tumors
- (2012) Y. Bai et al. CANCER RESEARCH
- An Epithelial-Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance
- (2012) L. A. Byers et al. CLINICAL CANCER RESEARCH
- Axl is essential for VEGF-A-dependent activation of PI3K/Akt
- (2012) Guo-Xiang Ruan et al. EMBO JOURNAL
- PTMScan Direct: Identification and Quantification of Peptides from Critical Signaling Proteins by Immunoaffinity Enrichment Coupled with LC-MS/MS
- (2012) Matthew P. Stokes et al. MOLECULAR & CELLULAR PROTEOMICS
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Profiling phospho-signaling networks in breast cancer using reverse-phase protein arrays
- (2012) T S Gujral et al. ONCOGENE
- Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer
- (2012) R M A Linger et al. ONCOGENE
- Axl glycosylation mediates tumor cell proliferation, invasion and lymphatic metastasis in murine hepatocellular carcinoma
- (2012) Ji Li WORLD JOURNAL OF GASTROENTEROLOGY
- Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA
- (2011) Mark Mackiewicz et al. BREAST CANCER RESEARCH AND TREATMENT
- Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer
- (2011) G Mudduluru et al. ONCOGENE
- Design, Synthesis, and Biological Evaluation of a Series of Novel AXL Kinase Inhibitors
- (2011) Alexis Mollard et al. ACS Medicinal Chemistry Letters
- PMA up-regulates the transcription of Axl by AP-1 transcription factor binding to TRE sequences via the MAPK cascade in leukaemia cells
- (2010) Giridhar Mudduluru et al. BIOLOGY OF THE CELL
- Induction, regulation, and biologic function of Axl receptor tyrosine kinase in Kaposi sarcoma
- (2010) R. Liu et al. BLOOD
- R428, a Selective Small Molecule Inhibitor of Axl Kinase, Blocks Tumor Spread and Prolongs Survival in Models of Metastatic Breast Cancer
- (2010) S. J. Holland et al. CANCER RESEARCH
- Myeloid Zinc Finger 1 Induces Migration, Invasion, and In vivo Metastasis through Axl Gene Expression in Solid Cancer
- (2010) G. Mudduluru et al. MOLECULAR CANCER RESEARCH
- AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma
- (2010) M Z Xu et al. ONCOGENE
- An anti-Axl monoclonal antibody attenuates xenograft tumor growth and enhances the effect of multiple anticancer therapies
- (2010) X Ye et al. ONCOGENE
- Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer
- (2010) K Vuoriluoto et al. ONCOGENE
- Malignant cells fuel tumor growth by educating infiltrating leukocytes to produce the mitogen Gas6
- (2009) S. Loges et al. BLOOD
- Novel Mechanism of Lapatinib Resistance in HER2-Positive Breast Tumor Cells: Activation of AXL
- (2009) L. Liu et al. CANCER RESEARCH
- Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis
- (2009) Y Li et al. ONCOGENE
- Axl is an essential epithelial-to-mesenchymal transition-induced regulator of breast cancer metastasis and patient survival
- (2009) C. Gjerdrum et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The human receptor tyrosine kinase Axl gene - promoter characterization and regulation of constitutive expression by Sp1, Sp3, and CpG methylation
- (2008) Giridhar Mudduluru et al. BIOSCIENCE REPORTS
- Receptor tyrosine kinase AXL is induced by chemotherapy drugs and overexpression of AXL confers drug resistance in acute myeloid leukemia
- (2008) Chih-Chen Hong et al. CANCER LETTERS
- AXL Is a Potential Target for Therapeutic Intervention in Breast Cancer Progression
- (2008) Y.-X. Zhang et al. CANCER RESEARCH
- Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-κB and Brg-1
- (2008) K-Y Tai et al. ONCOGENE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started